Wanbangde Pharmaceutical Holding Group Co Ltd Cash Flow Quality Index
Wanbangde Pharmaceutical Holding Group Co Ltd cash flow quality index. Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a Cash Flow Quality Index of -0.97x as of March 2025. Operating cash flow of CN¥-14.73 Million is below net income of CN¥15.20 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 002082 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2024)
Cash flow quality index of Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2024. Historical Cash Flow Quality Index for Wanbangde Pharmaceutical Holding Group Co Ltd across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Wanbangde Pharmaceutical Holding Group C balance sheet independence to measure how much of total assets are equity-financed.
Wanbangde Pharmaceutical Holding Group Co Ltd Cash Flow Quality Index by Year (2003–2024)
Wanbangde Pharmaceutical Holding Group Co Ltd cash flow quality index by year from 2003 to 2024. Year-by-year earnings quality comparison for Wanbangde Pharmaceutical Holding Group Co Ltd. For the full cash flow conversion analysis, see 002082 cash flow metrics.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.66x | CN¥120.22 Million | CN¥45.25 Million | ▲ +196.0% |
| 2023 | -2.77x | CN¥-72.87 Million | CN¥26.33 Million | ▲ +14.2% |
| 2022 | -3.22x | CN¥-239.65 Million | CN¥74.32 Million | ▼ -2452.9% |
| 2021 | 0.14x | CN¥22.09 Million | CN¥161.16 Million | ▼ -73.5% |
| 2020 | 0.52x | CN¥151.01 Million | CN¥292.21 Million | ▲ +143.4% |
| 2019 | -1.19x | CN¥-248.69 Million | CN¥208.83 Million | ▼ -210.1% |
| 2018 | 1.08x | CN¥135.40 Million | CN¥125.19 Million | ▲ +716.9% |
| 2017 | -0.18x | CN¥-17.60 Million | CN¥100.41 Million | ▼ -104.1% |
| 2016 | 4.23x | CN¥310.71 Million | CN¥73.38 Million | ▲ +1628.5% |
| 2015 | 0.24x | CN¥16.76 Million | CN¥68.43 Million | ▼ -80.2% |
| 2014 | 1.24x | CN¥140.31 Million | CN¥113.35 Million | ▼ -38.1% |
| 2013 | 2.00x | CN¥234.35 Million | CN¥117.26 Million | ▼ -10.3% |
| 2012 | 2.23x | CN¥202.73 Million | CN¥90.94 Million | ▲ +25304.7% |
| 2011 | -0.01x | CN¥-1.44 Million | CN¥162.46 Million | ▼ -100.8% |
| 2010 | 1.04x | CN¥162.26 Million | CN¥155.48 Million | ▲ +88.5% |
| 2009 | 0.55x | CN¥68.13 Million | CN¥123.08 Million | ▼ -83.5% |
| 2008 | 3.35x | CN¥253.06 Million | CN¥75.54 Million | ▲ +1649.1% |
| 2007 | 0.19x | CN¥12.45 Million | CN¥65.02 Million | ▲ +101.5% |
| 2006 | 0.10x | CN¥3.50 Million | CN¥36.84 Million | ▼ -82.6% |
| 2005 | 0.55x | CN¥11.23 Million | CN¥20.56 Million | ▼ -56.8% |
| 2004 | 1.26x | CN¥32.69 Million | CN¥25.85 Million | ▼ -30.9% |
| 2003 | 1.83x | CN¥37.01 Million | CN¥20.23 Million | — |